t-PA trial for central retinal artery occlusio
- Conditions
- central retinal artery occlusionartery occlusionH341
- Registration Number
- JPRN-jRCTs041190079
- Lead Sponsor
- Hayashi Atsushi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
1.Patients older than 20
2.Diagnosed with central retinal artery occulusion within 24 hours
3.Treated with pars plana vitrectomy as an inpatient in this research facility
4.No history of cerebrovascular disease such as stroke,
and judged that drug used in this research is not deterioration factor
5.Obtain written informed consent
1.Expected that the drug influence previous disease
2.central retinal artery occlusion more than 24 hours after the onset
3.Pregnant, possibile pregnancy or hope for pregnancy during the study period
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity at 12 weeks after the first operation
- Secondary Outcome Measures
Name Time Method Changes in visual acuity and central retinal thickness at 12 weeks after the first operation